Debra Montague

Debra Montague has over 25 years of experience at a senior level in the pharmaceutical industry. She retired for health reasons when diagnosed with Stage IV ALK-positive lung cancer in 2016. Her personal experience with lung cancer pushed her to advocate for better screening and prevention policies to improve cancer patients’ health outcomes with the promotion of early detection. She founded the ALK Positive Lung Cancer (UK) charity in December 2018 and membership, including patients and families, is now at 690. The charity provides support to, empowerment of and advocacy on behalf of patients. Debra is also Vice-President of Lung Cancer Europe and a board member of ALK Positive Europe.